287 related articles for article (PubMed ID: 25688123)
1. Cyclical suicidal ideation following natalizumab infusion for multiple sclerosis.
Nagesh O; Bastiampillai T; Fisher L; Mohan T
Aust N Z J Psychiatry; 2015 Jul; 49(7):668-9. PubMed ID: 25688123
[No Abstract] [Full Text] [Related]
2. Evolution of MRI appearances due to progressive multifocal leucoencephalopathy following natalizumab treatment for multiple sclerosis.
Campbell S; Kanodia AK; O'Riordan J
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25878241
[No Abstract] [Full Text] [Related]
3. Localized sporotrichosis during natalizumab treatment in Multiple Sclerosis.
Marques PT; Kay CSK; Basílio FMA; Pinheiro RL; Werneck LC; Lorenzoni PJ; Scola RH
Mult Scler Relat Disord; 2020 Jun; 41():102029. PubMed ID: 32155462
[No Abstract] [Full Text] [Related]
4. Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab.
Durrieu G; Dardonville Q; Clanet M; Montastruc JL
Fundam Clin Pharmacol; 2019 Feb; 33(1):125-126. PubMed ID: 29935014
[TBL] [Abstract][Full Text] [Related]
5. Natalizumab-associated cerebellar PML: a case report on how to slow down IRIS.
Lauda F; Fangerau T; Javaheripour-Otto K; Pinkhardt E; Kassubek J; Tumani H
J Neurol; 2015; 262(4):1055-7. PubMed ID: 25663412
[No Abstract] [Full Text] [Related]
6. [Natalizumab can induce progressive multifocal leucoencephalopathy].
Theódórsdóttir A; Blaabjerg M; Falah M
Ugeskr Laeger; 2014 Aug; 176(35):. PubMed ID: 25293706
[TBL] [Abstract][Full Text] [Related]
7. Natalizumab treatment for multiple sclerosis inducing a toxic acute myocardial damage. Is there any relationship?
Fama' F; Dattola V; Cicciu' M; Buccafusca M; Russo M; Lo Presti D; Dattilo G; Di Bella G
Int J Cardiol; 2016 Mar; 206():127-8. PubMed ID: 26788687
[No Abstract] [Full Text] [Related]
8. Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR).
Sabol RA; Noxon V; Sartor O; Berger JR; Qureshi Z; Raisch DW; Norris LB; Yarnold PR; Georgantopoulos P; Hrushesky WJ; Bobolts L; Ray P; Lebby A; Kane RC; Bennett CL
Cancer Med; 2017 Jul; 6(7):1541-1551. PubMed ID: 28635055
[TBL] [Abstract][Full Text] [Related]
9. Natalizumab exposure during pregnancy in multiple sclerosis: a systematic review.
Peng A; Qiu X; Zhang L; Zhu X; He S; Lai W; Chen L
J Neurol Sci; 2019 Jan; 396():202-205. PubMed ID: 30502611
[No Abstract] [Full Text] [Related]
10. How safe is natalizumab during pregnancy?
Duquette P; Prat A
Mult Scler; 2015 Feb; 21(2):121-2. PubMed ID: 25392323
[No Abstract] [Full Text] [Related]
11. Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.
Bourre B; Gueudry J; Lefaucheur R; Borden A; Maltête D; Patel SS; Van Tassel SH; Gupta MP; Orlin A; Nealon NM
Neurology; 2016 Jan; 86(3):312-3. PubMed ID: 26783270
[No Abstract] [Full Text] [Related]
12. Natalizumab induced cutaneous sarcoidosis-like reaction.
Durcan R; Heffron C; Sweeney B
J Neuroimmunol; 2019 Aug; 333():476955. PubMed ID: 31108403
[TBL] [Abstract][Full Text] [Related]
13. Home infusions of natalizumab for people with multiple sclerosis: a pilot randomised crossover trial.
Schultz TJ; Thomas A; Georgiou P; Juaton MS; Cusack L; Simon L; Naidoo K; Webb K; Karnon J; Ravindran J
Ann Clin Transl Neurol; 2021 Aug; 8(8):1610-1621. PubMed ID: 34288591
[TBL] [Abstract][Full Text] [Related]
14. Transfer of natalizumab into breast milk in a mother with multiple sclerosis.
Baker TE; Cooper SD; Kessler L; Hale TW
J Hum Lact; 2015 May; 31(2):233-6. PubMed ID: 25586712
[TBL] [Abstract][Full Text] [Related]
15. [Increased disease activity in a case of multiple sclerosis after switching treatment from fingolimod to natalizumab].
Akatani R; Chihara N; Katanazaka K; Ueda T; Sekiguchi K; Matsumoto R
Rinsho Shinkeigaku; 2019 Aug; 59(8):536-540. PubMed ID: 31341130
[TBL] [Abstract][Full Text] [Related]
16. Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
Fragoso YD; Gama PDD; Gomes S; Khouri JMN; Matta APDC; Fernanda Mendes M; Stella CRAV
Mult Scler Relat Disord; 2016 Mar; 6():64-65. PubMed ID: 27063625
[TBL] [Abstract][Full Text] [Related]
17. Myocardial infarction in a patient with multiple sclerosis after receiving natalizumab.
Darki A; Masoumi P; Soleimani A; Naser Moghadasi A
Mult Scler Relat Disord; 2018 Oct; 25():26-28. PubMed ID: 30025371
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis.
Frisell T; Forsberg L; Nordin N; Kiesel C; Alfredsson L; Askling J; Hillert J; Olsson T; Piehl F
Mult Scler; 2016 Jan; 22(1):85-93. PubMed ID: 25921036
[TBL] [Abstract][Full Text] [Related]
19. Acute retinal necrosis and immune reconstitution inflammatory syndrome in a natalizumab-treated patient with multiple sclerosis.
Saraiva VS
Retin Cases Brief Rep; 2015; 9(3):195-7. PubMed ID: 25933353
[TBL] [Abstract][Full Text] [Related]
20. Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.
Yamout BI; Abou Zeid N; Taha AJ; Zeineddine MM; Khoury SJ
Mult Scler Relat Disord; 2016 Sep; 9():122-4. PubMed ID: 27645358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
